| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $139.5M | — | -79.1% |
| Cost of Revenue | $30.7M | — | +117.5% |
| R&D Expense | $95.5M | — | +7.3% |
| SG&A Expense | $28.8M | — | -40.2% |
| Operating Income | -$15.4M | — | -103.0% |
| Interest Expense | $3.7M | — | +42.1% |
| Pre-tax Income | -$8.5M | — | -101.6% |
| Income Tax | $985K | — | -17.9% |
| Net Income | -$9.5M | — | -101.8% |
| EPS (Basic) | -$0.06 | — | -101.9% |
| EPS (Diluted) | -$0.06 | — | -102.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $228.4M | -5.1% | -13.3% |
| Short-term Investments | $562.0M | +13.7% | +20.0% |
| Inventory | $11.5M | -0.8% | +11.6% |
| Current Assets | $850.8M | -13.0% | -2.0% |
| Total Assets | $1.04B | -11.3% | -19.3% |
| Current Liabilities | $342.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$32.4M | — | +82.5% |
| Capital Expenditures | $1.3M | — | +4.1% |
| Investing Cash Flow | -$28.4M | — | +61.3% |
| Financing Cash Flow | $37.7M | — | +633.6% |
| Free Cash Flow | -$33.7M | — | +82.0% |
| -18.9% |
| Long-term Debt | $291.0M | +19.2% | — |
| Total Liabilities | $1.19B | -8.9% | -13.2% |
| Stockholders' Equity | -$144.8M | -13.3% | -91.4% |